홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → (4R,6R)-6-{2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6-t-butyldimethylsilyloxy-8-(2-ethyl-2-methylbutyryloxy)-2-methyl-1-naphthyl]ethyl}tetrahydro-4-t-butyldimethylsilyloxy-2H-pyran-2-one

HRID 400137
인쇄

반응식

HRID 400137 반응식
C(N(CC)CC)C.N1(C2C=CN=CC=2)CCCC1.[CH2:19]([C:21]([CH3:27])([CH2:25][CH3:26])[C:22](Cl)=[O:23])[CH3:20].[Si:28]([O:35][C@H:36]1[CH2:45][C@H:44]([OH:46])[C@H:43]2[C:38]([CH:39]=[CH:40][C@H:41]([CH3:64])[C@@H:42]2[CH2:47][CH2:48][C@H:49]2[O:54][C:53](=[O:55])[CH2:52][C@H:51]([O:56][Si:57]([C:60]([CH3:63])([CH3:62])[CH3:61])([CH3:59])[CH3:58])[CH2:50]2)=[CH:37]1)([C:31]([CH3:34])([CH3:33])[CH3:32])([CH3:30])[CH3:29]>C1C=CC=CC=1.C(OCC)(=O)C>[Si:28]([O:35][C@H:36]1[CH2:45][C@H:44]([O:46][C:22](=[O:23])[C:21]([CH2:25][CH3:26])([CH3:27])[CH2:19][CH3:20])[C@H:43]2[C:38]([CH:39]=[CH:40][C@H:41]([CH3:64])[C@@H:42]2[CH2:47][CH2:48][C@H:49]2[O:54][C:53](=[O:55])[CH2:52][C@H:51]([O:56][Si:57]([C:60]([CH3:63])([CH3:62])[CH3:61])([CH3:58])[CH3:59])[CH2:50]2)=[CH:37]1)([C:31]([CH3:32])([CH3:33])[CH3:34])([CH3:30])[CH3:29]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 8471TriethylamineHCID 755674-PyrrolidinopyridineHCID 111162192-Ethyl-2-methylbutanoyl chlorideHCID 14600906Pravastatin Diol Lactone Di-(tert-butyldimethylsilyl) Ether

생성물 1

HCID 15285943(4R,6R)-6-{2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6-t-butyldimethylsilyloxy-8-(2-ethyl-2-methylbutyryloxy)-2-methyl-1-naphthyl]ethyl}tetrahydro-4-t-butyldimethylsilyloxy-2H-pyran-2-one
수율 100%

시약·촉매·용매 2

HCID 241Benzene용매HCID 8857Ethyl Acetate용매

실험 절차

0.76 ml (5.4 mmol) of triethylamine, 807 mg (5.4 mmol) of 4-(1-pyrrolidinyl)pyridine and 674 mg (4.5 mmol) of 2-ethyl-2-methylbutyryl chloride were added to a solution of 500 mg (0.91 mmol) of (4R,6R)-6-{2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-6-t-butyldimethylsilyloxy-8-hydroxy-2-methyl-1-naphthyl]ethyl}tetrahydro-4-t-butyldimethylsilyloxy-2H-pyran-2-one [prepared as described in Example B, above] in 10 ml of benzene and the resulting mixture was heated under reflux for 5 hours. At the end of this time, the reaction mixture was diluted with 50 ml of ethyl acetate. The diluted mixture was then washed with 30 ml of water, 30 ml of a 10% w/v aqueous solution of citric acid, a saturated aqueous solution of sodium hydrogencarbonate and a saturated aqueous solution of sodium chloride, in that order. The organic phase was then dried over anhydrous magnesium sulfate, after which this phase was filtered. The filtrate was concentrated by evaporation under reduced pressure and the concentrate was purified by flash column chromatography through silica gel, using a 5:1 by volume mixture of hexane and ethyl acetate as the eluent, to give 601 mg (100% yield) of the title compound.

후처리

  1. customprepared
  2. temperatureunder reflux for 5 hours
  3. washThe diluted mixture was then washed with 30 ml of water, 30 ml of a 10% w/v aqueous solution of citric acid
  4. dry with materialThe organic phase was then dried over anhydrous magnesium sulfate
  5. filtrationafter which this phase was filtered
  6. concentrationThe filtrate was concentrated by evaporation under reduced pressure
  7. customthe concentrate was purified by flash column chromatography through silica gel
  8. additionby volume mixture of hexane and ethyl acetate as the eluent

출처 및 근거

ORD 기록
ord-d8027d269e444297a0a7b69585febbd6
출처 데이터셋
uspto-grants-1998_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05827855

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트